Current location:Home > Non-metabolic Pipeline

Non-metabolic Pipeline

Explore Gan & Lee’s non-metabolic pipeline across oncology, ophthalmology, and immunology.
  • PHASE 1 · CHINA
    GLR2037
    AR PROTAC degrader for the treatment of prostate cancer.

     

    MoA AR PROTAC
    Indication Prostate Cancer
  • PHASE 1 · CHINA
    GLR1059
    Nectin-4 antibody-drug conjugate for advanced solid tumors.

     

    MoA Nectin-4 ADC
    Indication Advanced Solid Tumors
  • PHASE 1 · CHINA
    GLR1062
    rAAV-based VEGF antagonist for neovascular age-related macular degeneration.

     

    MoA rAAV-based VEGF Antagonist
    Indication Neovascular Age-related Macular Degeneration (nAMD)
  • PHASE 1 · CHINA
    GLR1023
    Secukinumab biosimilar for the treatment of psoriasis.

     

    MoA IL-17A mAb
    Indication Psoriasis

     

  • IND · CHINA
    GLR1044
    Dupilumab biosimilar for the treatment of atopic dermatitis.

     

    MoA IL-4Rα mAb
    Indication Atopic Dermatitis